Pierre Cardinal

Learn More
Management of patients with adult respiratory distress syndrome (ARDS) has been a therapeutic challenge for years. Despite scientific interest, there has been a lack of high quality clinical studies demonstrating a mortality benefit. In 2000 a large trial funded by the US National Institutes of Health (NIH) [1] demonstrated a 9% reduction in absolute(More)
  • 1